China Medical University Hospital has announced an upcoming study focusing on depression and sleep disturbances in older adults, leveraging wearable technology. The research, which has not yet started recruiting participants, incorporates innovative devices to explore potential treatments.
What is the focus of this study?
This clinical trial aims to investigate the challenges of elderly depression and sleep disturbances—a growing health concern as global populations age. Participants will be observed using wearable technologies to track sleep patterns and mental health markers, ultimately addressing how these conditions might interrelate.
What interventions will be used?
The study will test two devices: one offering photobiomodulation treatment and a sham device acting as a control. Photobiomodulation, a non-invasive therapy, uses light to enhance cellular performance. It may hold promise for improving mood disorders and sleep disturbances in older demographics. The sham device assists in measuring placebo effects to ensure trial validity.
When will recruitment begin?
As of November 18, 2025, the study is classified as “not yet recruiting.” Updates on recruitment timelines and detailed participant criteria should become available soon on the official listing.
FAQ
- 1. What is photobiomodulation?
- It is a treatment that uses light to stimulate cellular processes and promote healing or improve functions.
- 2. Who is eligible to participate?
- The study appears to target elderly individuals experiencing depression or sleep issues. Specific criteria will be available on the official trial page.
- 3. How are the devices regulated?
- All devices used in the study comply with applicable medical device regulations for safety and clinical investigations.
Conclusion
The upcoming study highlights an innovative step toward understanding elderly depression and sleep disturbances. It demonstrates the growing role of wearable devices in advancing mental health care and sleep treatment. Stakeholders in clinical and regulatory settings are encouraged to follow its progress.
Disclaimer
This article is informational and not intended as legal or clinical advice. Healthcare professionals should assess the trial details directly.
Full Announcement
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07232472?term=medical+device